ID   mEC25
AC   CVCL_C6JH
DR   Wikidata; Q116049782
RX   PubMed=32510874;
CC   Doubling time: 26.8 hours (Note=At 20th passage), 25.8 hours (Note=At 50th passage) (PubMed=32510874).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C191763; Mouse esophageal squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   30W
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
RX   PubMed=32510874; DOI=10.1002/cac2.12066; PMCID=PMC7365451;
RA   Huang, Tu-Xiong
RA   Yang, Jiao
RA   Liu, Bei-Lei
RA   Fu, Li
RT   "A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical
RT   syngeneic tumor model for immunotherapy.";
RL   Cancer Commun. (Lond.) 40:316-320(2020).
//